Valuation: Amarin Corporation plc

Market Cap 296M 256M 242M 219M 412M 28.37B 415M 2.89B 1.11B 14.38B 1.11B 1.09B 45.87B P/E 2026 *
-200x
P/E 2027 * -233x
Enterprise Value 133M 116M 109M 98.95M 186M 12.8B 187M 1.3B 502M 6.49B 501M 490M 20.7B EV / Sales 2026 *
0.75x
EV / Sales 2027 * 0.68x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-1.14%
1 week-2.74%
Current month-0.14%
1 month-1.07%
3 months-9.71%
6 months-10.12%
Current year-0.68%
1 week 13.68
Extreme 13.68
14.4
1 month 13.19
Extreme 13.19
15.24
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
110.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
1/8/26 Exercice

Chief Financial Officer

781 0.0002%
1/7/26 Exercice

Chief Operating Officer

9,302 0.0022%
1/7/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-2.74%-7.17%-31.39% 296M
-1.38%+2.23%+48.54%+100.96% 70.24B
-1.04%-0.81%+34.61%+75.16% 62.63B
-5.09%-4.39%-16.58%+348.74% 27.36B
+0.16%+1.53%+34.92%+17.47% 25.71B
-1.69%-1.25%-0.47%-13.83% 24.83B
+1.61%-0.69%+20.85%-19.42% 19.52B
+1.26%-9.06%+165.21%+308.08% 15.51B
-3.91%-5.71%-8.71%+521.92% 14.66B
-6.68%-0.55%-9.27%+818.98% 14.69B
Average -1.80%-0.93%+26.20%+212.67% 27.55B
Weighted average by Cap. -1.62%-0.64%+31.63%+165.27%

Financials

2026 *2027 *
Net sales 177M 154M 145M 132M 247M 17.02B 249M 1.73B 667M 8.63B 667M 652M 27.52B 177M 153M 145M 131M 246M 16.96B 248M 1.73B 665M 8.6B 664M 650M 27.43B
Net income -26.62M -23.06M -21.81M -19.74M -37.05M -2.55B -37.33M -260M -100M -1.29B -100M -97.79M -4.13B -18.32M -15.87M -15M -13.58M -25.5M -1.76B -25.69M -179M -68.89M -891M -68.81M -67.29M -2.84B
Net Debt -162M -141M -133M -120M -226M -15.57B -228M -1.59B -610M -7.89B -610M -596M -25.17B -175M -151M -143M -130M -243M -16.78B -245M -1.71B -658M -8.51B -657M -642M -27.13B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
16/09/26 USD 13.86 -1.00% 19,781
14/09/26 USD 14.00 +1.45% 38,269
11/09/26 USD 13.80 -1.71% 49,369
10/09/26 USD 14.04 -2.43% 51,753
09/09/26 USD 14.39 +0.98% 33,687
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
14.00USD
Average target price
12.50USD
Spread / Average Target
-10.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!